Skip to main content
Premium Trial:

Request an Annual Quote

Pfizer Joins Canadian Personalized Oncology Testing Consortium

NEW YORK (GenomeWeb) – Contextual Genomics and the Personalized Medicine Initiative today announced that Pfizer Canada has joined the National Access Project for Cancer Testing.

Pfizer Canada has provided a grant of an undisclosed amount and technical support as part of its commitment to the consortium, whose goal is to provide genomic testing to all Canadians diagnosed with cancer and to accelerate a personalized approach to treating the disease.

The National Access Project launched in February and is managed by the Personalized Medicine Initiative. Contextual Genomics provides a 90-mutation cancer genomics test for 2,000 Canadian cancer patients, free of charge, as part of the project. Each mutation that is identified is treated with current medications or Phase III investigational treatments. 

In February, drug maker AstraZeneca joined the consortium.

The Scan

Pig Organ Transplants Considered

The Wall Street Journal reports that the US Food and Drug Administration may soon allow clinical trials that involve transplanting pig organs into humans.

'Poo-Bank' Proposal

Harvard Medical School researchers suggest people should bank stool samples when they are young to transplant when they later develop age-related diseases.

Spurred to Develop Again

New Scientist reports that researchers may have uncovered why about 60 percent of in vitro fertilization embryos stop developing.

Science Papers Examine Breast Milk Cell Populations, Cerebral Cortex Cellular Diversity, Micronesia Population History

In Science this week: unique cell populations found within breast milk, 100 transcriptionally distinct cell populations uncovered in the cerebral cortex, and more.